Valneva SE (LTS:0OB3) Total Operating Expense : €138.6 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Valneva SE Total Operating Expense?

Valneva SE's Total Operating Expense for the three months ended in Mar. 2024 was €33.2 Mil. Valneva SE's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €138.6 Mil.

Valneva SE Total Operating Expense Historical Data

The historical data trend for Valneva SE's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Total Operating Expense Chart

Valneva SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Operating Expense

Get a 7-Day Free Trial

74.23

111.14

221.51

150.24

134.95

Valneva SE Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Operating Expense	Get a 7-Day Free Trial															29.60	25.26	39.32	40.76	33.22

Valneva SE Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €138.6 Mil.

Valneva SE Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Valneva SE's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Valneva SE (LTS:0OB3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (LTS:0OB3) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

VALN:USA INRLF:USA VLA:France AYJ:Germany AYJ0:Germany AYJ0:Germany AYJ:Germany AYJ:Germany AYJ:Germany VLA:Austria

Address

6 Rue Alain Bombard, Saint-Herblain, FRA, 44800

Website

https://www.valneva.com

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, & third-party products; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The majority is from the Commercialized vaccines segment & geographically from the United States.

Valneva SE (LTS:0OB3) Headlines

No Headlines